Financials
- Market Capitalization 620.82 M
- Employee 88
- Founded 1994
- CEO Craig A Tooman
- Website www.silence-therapeutics.com
- Headquarter United Kingdom
- FIGI BBG00WVTHPN2
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-24.95
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2759 | SGMT Sagimet Biosciences Inc. - Series A Common Stock | 10.27 USD | -2.65% | +0.79% | +52.37% | +38.60% | 638.37 M USD | ||
| 2770 | HELP Cybin Inc. - Common Stock | 12.18 USD | -8.01% | -5.21% | +54.18% | +35.79% | 628.88 M USD | ||
| 2788 | AUTL Autolus Therapeutics plc - American Depositary Shares | 2.32 USD | -0.85% | -2.52% | +34.88% | +56.76% | 617.50 M USD | ||
| 2796 | TECX Tectonic Therapeutic, Inc. - Common Stock | 31.01 USD | -12.94% | -13.26% | +11.55% | +80.82% | 606.23 M USD |